Department of Sensory Organs, Sapienza University of Rome, Italy.
Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):183-91. doi: 10.1177/039463201202500121.
Jugulo-tympanic paragangliomas are the most common primary neoplasm of the middle ear, but little is still known about the histological features differentiating the benign and malignant forms. We investigated, with an immunohistochemical procedure, the expression of neurotrophins with their receptors, in fifteen samples of paragangliomas, and MIB-1 in order to consider them as prognostic factors of malignancy. We observed a general positivity for NGF - TrKA - NT4 - TrKC in the cytoplasm, and a strong expression for BDNF in the extracellular space. MIB-1 was moderate in the nucleus of neoplastic cells, weak in the cytoplasm and totally absent in the extracellular space. The comparison between the clinical recurrences and the rate of cytoplasmatic neurotrophins showed strong immunoreactivity in recurrent patients. It should be emphasized that 2 of the 3 recurrences had a wider distribution of the neutrophins, leading to hypothesize the involvement of these substances in the cell proliferation of glomus tumors. Malignant forms of these rare glomus tumors cannot be clearly identified using MIB-1 as a prognostic marker, although we can affirm that neurotrophins and their receptors can be considered as a panel of potential diagnostic markers to monitor the development of such malignancies. Although the small number of patients does not allow definitive conclusions to be made, our findings showed a possible trend towards significance which requires a more powerful study to evaluate this further.
鼓室-颈静脉球部副神经节瘤是中耳最常见的原发性肿瘤,但对于良性和恶性形式的组织学特征仍知之甚少。我们通过免疫组织化学程序研究了十五例副神经节瘤中神经生长因子及其受体、MIB-1 的表达,以将其视为恶性肿瘤的预后因素。我们观察到神经生长因子在细胞质中普遍呈阳性-TrKA-NT4-TrKC,BDNF 在细胞外空间中呈强阳性表达。MIB-1 在肿瘤细胞核中呈中等强度,在细胞质中较弱,在细胞外空间中完全缺失。在临床复发和细胞质神经生长因子的比率之间的比较中,复发病例表现出强烈的免疫反应性。值得强调的是,在 3 例复发病例中,有 2 例神经生长因子的分布更广泛,这导致我们假设这些物质参与了球瘤细胞的增殖。尽管我们可以肯定的是,神经生长因子及其受体可以被认为是一组潜在的诊断标志物,以监测这些恶性肿瘤的发展,但 MIB-1 不能作为一种预后标志物来明确识别这些罕见的副神经节瘤的恶性形式。虽然患者数量较少,但不能得出明确的结论,但我们的发现显示出一种可能的趋势,需要更强大的研究来进一步评估。